Kymera Therapeutics (KYMR) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,964.20+0.49%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Kymera Therapeutics Inc (KYMR) Stock Price, Quote, News & History

KYMRNASDAQ

Trade with Public

Trade with Public

$112.40

3.102.84%

Last update: Oct 9, 4:00 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$109.54

Close

$112.40

Volume / Avg.

1.30M / 705.11K

Day Range

$112.40 - $112.40

52 Wk Range

55.26 - 130.05

Market Cap

$9.09B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

15.33%

Days to Cover

11.97

Recent Kymera Therapeutics, Inc. News

This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiate coverage: Outperform on American Express and Kymera, Overweight on Kratos, Hold on IBM and Neutral on Duos.

Avi Kapoor

This SK Hynix Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Top Wall Street analysts changed their outlook on various stocks. Check out the analyst ratings page for upgrades, downgrades, and initiations.

Avi Kapoor

Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program

Kymera Therapeutics shares surged after completing KT-621 Phase 2b enrollment early, accelerating data timing and Phase 3 plans.

Vandana Singh

Gold Gains Over 1%; Fed's Preferred Inflation Gauge Surges To 3-Year High

U.S. stocks traded mostly higher, with the Nasdaq Composite down 0.1%. Industrials jumped 2.5%, while consumer discretionary fell 1.1%. Core PCE rose 3.4% in May.

Avi Kapoor

Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday

Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial results, shares rose 17.1%; other big stocks also gained.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-236.76M

Investing Cash Flow (TTM)

-752.49M

Financing Cash Flow (TTM)

777.92M

Free Cash Flow (TTM)

-237.96M

Capital Expenditure (TTM)

-1.19M

Net Change in Cash (TTM)

-211.34M

Analyst Trends and Forecast

2

Jul

3

Aug

3

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.73B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

97.09

PB Ratio (TTM)

6.02

Earnings Yield % (TTM)

-2.97%

Earnings Yield % (FWD)

-4.83%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$18.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.70M

Total Cash

$124.48M

Debt to Equity

0.05

Issuance of Debt (TTM)

-$1.70M

Repayment of Debt (TTM)

-$1.70M